With the availability of recombinant CagA [50,51], ELISA assays to determine CagA IgG seropositivity in the gastric cancer precursor condition corpus atrophy and non-cardia gastric cancer has been the focus of many studies. This evidence concerns the gene S100A8 and gastric neoplasm.